Clark level risk stratifies patients with mitogenic thin melanomas for sentinel lymph node biopsy.
Bartlett EK, Gimotty PA, Sinnamon AJ, Wachtel H, Roses RE, Schuchter L, Xu X, Elder DE, Ming M, Elenitsas R, Guerry D, Kelz RR, Czerniecki BJ, Fraker DL, Karakousis GC.
Bartlett EK, et al. Among authors: elenitsas r.
Ann Surg Oncol. 2014 Feb;21(2):643-9. doi: 10.1245/s10434-013-3313-y. Epub 2013 Oct 12.
Ann Surg Oncol. 2014.
PMID: 24121883
Free PMC article.
Clinical Trial.